Skip to content

Bidirectional cohort study on the effects of CPAP therapy on glucose metabolism in OSA patients with prediabetes

Bidirectional cohort study on the effects of CPAP therapy on glucose metabolism in OSA patients with prediabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097843
Enrollment
Unknown
Registered
2025-02-26
Start date
2023-10-11
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea, OSA

Interventions

CPAP compliance group:None
CPAP non-compliant group:None

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with OSA by the Department of Psychiatry and Psychology (Sleep Medicine Center) of Nanfang Hospital meet the following criteria: (2) Age 18-65 years old; (3) Complete polysomnography and the data are valid; (4) Meet the diagnostic criteria for prediabetes, and have not been diagnosed with diabetes or taken hypoglycemic drugs; In addition to the above criteria, the inclusion criteria for prospective studies must also meet: fully informed of the content of this study and signed informed consent. In addition to the above criteria, the inclusion criteria for the retrospective study must also be met: Patient in Nanfang Hospital, Southern Medical University from January 2010 to May 2021.

Exclusion criteria

Exclusion criteria: (1) Other respiratory diseases that can cause chronic hypoxia, such as chronic bronchitis, COPD, asthma, etc; Accompanied by disrupted circadian rhythms, long-term staying up late or night shifts, and other sleep disorders; (2) Long term use of drugs that can cause glucose metabolism disorders, such as olanzapine, mirtazapine, oral contraceptives, sympathomimetic drugs, glucocorticoids, etc; (3) Cancer patients with a history of major surgery, major trauma in the past 3 months, and recent radiotherapy and chemotherapy treatment; (4) Individuals with important physical disorders such as neuromuscular disorders, hematological disorders, autoimmune diseases, liver diseases, hyperthyroidism, hypothyroidism, etc; (5) Acute coronary syndrome and/or cerebrovascular accident within 3 months; (6) People with congenital diseases or mental illnesses, or those with consciousness disorders who cannot cooperate; (7) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
75g OGTT test 2-hour blood glucose;

Secondary

MeasureTime frame
75g OGTT test 1-hour blood glucose;Fasting blood glucose;Fasting insulin;HbA1c;Apnea Hypopnea Index, AHI;Average blood oxygen saturation;Lowest oxygen saturation ;

Countries

China

Contacts

Public ContactFeng Yuan

Nanfang Hospital, Southern Medical University

yuanstar@126.com+86 138 2502 7946

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026